“NICHIGLUCAN- potentials and clinical studies published in “Agro FOOD Industry- Hi tech”, an Italian magazine.
Blog
13 years of basic research data of GN Corporation published in paper
GN Corporation published 13 years of basic research data in The Tokai Journal of Experimental and Clinical Medicine.
New Advances in Regenerative Treatments for Cartilage Injuries Published in THE KNEE
GNC succeeded in culturing hyaluronic acid-rich chondrocytes in a 3D tissue engineering platform.
The Potential of Nichi Glucan as a Vaccine Adjuvant
A paper describing the potentials of Nichi Glucan as Vaccine Ajuvant is published.
Bio Europe Spring 2021へ参加
GN Corporation is participating in Bio Europe Spring 2021.
Nichi Glucan has been published in NutraIngredients-Asia
Our product, Nichi glucan, has been published in N…
GN Corporation was featured in Eurobiz Japan
GN Corporation was featured in a business magazine as one of the companies with sustainable production.
Initiation of joint research with Oakyama University
Dr. Senthil Kumar Rajappa, whose arrival in Japan …
Biotech Showcase 2021
GN Corporation is participating in Biotech Showcase 2021.
A paper on the potential of Nichi Glucan to prevent complications of coronavirus infection has been published in a journal.
It argues that Nichiglucan may prevent complications by balancing blood sugar, lipids, and blood clotting.